证券代码：002690 证券简称：美亚光电 公告编号：2023-028 合肥美亚光电技术股份有限公司 2023年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 （2）现场会议召开地点：合肥市高新技术产业开发区望江西路668号公司会 议室 特别提示： 1、本次股东大会未出现否决议案的情形； 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 合肥美亚光电技术股份有限公司（以下简称"公司"）董事会于2023年8月 24日在《证券时报》、巨潮资讯网（http://www.cninfo.com.cn）上刊登了《关 于召开2023年第一次临时股东大会的通知》。 1、会议召开情况 （1）会议召开时间 现场会议时间：2023 年 9 月 12 日下午 14:30 网络投票时间： 通过深圳证券交易所交易系统进行网络投票的具体时间为 2023 年 9 月 12 日上 午 9:15—9:25、9:30－11:30 和下午 13:00－15:00。 通过深圳证券交易所互联网投票系统投票的具体时间为 2023 年 9 月 12 日 ...

合肥美亚光电技术股份有限公司 章程 二〇二三年九月 目 录 第一章 总则 第二章 经营宗旨和范围 第三章 股份 第一节 股份发行 第二节 股份增减和回购 第三节 股份转让 第四章 股东和股东大会 第一节 股东 第二节 股东大会的一般规定 第三节 股东大会的召集 第四节 股东大会的提案与通知 第五节 股东大会的召开 第六节 股东大会的表决和决议 第五章 董事会 第一节 董事 第二节 董事会 第六章 总经理及其他高级管理人员 第七章 监事会 第一节 监事 第二节 监事会 第八章 财务会计制度、利润分配和审计 第一节 财务会计制度 第二节 内部审计 第三节 会计师事务所的聘任 第九章 通知与公告 第一节 通知 第二节 公告 第十章 合并、分立、增资、减资、解散和清算 第一节 合并、分立、增资和减资 第二节 解散和清算 第十一章 修改章程 英文名称：Hefei Meyer Optoelectronic Technology Inc. 第五条 公司住所：合肥市高新区望江西路 668 号，邮政编码:230088。 第六条 公司注册资本为人民币 882,482,900 元。 第七条 公司营业期限为永久存续的股份有限公司。 ...

证券代码：002690 证券简称：美亚光电 公告编号：2023-027 合肥美亚光电技术股份有限公司 关于高级管理人员变动的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏。 为确保公司财务管理工作的顺利开展，公司于2023年9月8日召开的第五届董 事会第四次会议，审议通过了《关于聘任财务总监的议案》，决定聘任陈凯先生 为公司财务总监（简历附后）。陈凯先生任期自董事会审议通过之日起至第五届 董事会届满之日为止。 公司独立董事就上述事项发表了明确同意的独立意见。 1 三、备查文件 特此公告。 一、高级管理人员辞职情况 合肥美亚光电技术股份有限公司（以下简称"公司"）董事会于近日收到副 总经理、财务总监张浩先生的辞职申请，由于个人原因，张浩先生申请辞去公司 副总经理及财务总监职务，辞职后张浩先生将不再担任公司其他任何职务。 根据《公司法》、《深圳证券交易所上市公司自律监管指引第1号——主板 上市公司规范运作》等有关规定，张浩先生提交的辞职申请自送达董事会之日起 生效。本公司及董事会对张浩先生在担任相关职务期间勤勉尽职的工作及在公司 治理中发挥的作用表示衷心的感谢。 ...

合肥美亚光电技术股份有限公司 经审阅陈凯先生的个人履历，未发现有《公司法》第一百四十六条规定之情 形，未受过中国证监会及其他有关部门的处罚和证券交易所惩戒，也不存在其他 不得担任上市高级管理人员的情形。经了解，其教育背景、工作经历和身体状况 能够胜任公司相应岗位的职责要求，有利于公司的发展。提名、审议、表决程序 符合相关法律法规及《公司章程》等有关规定。因此，我们同意聘任陈凯先生为 公司财务总监，任期自本次会议审议通过之日起至第五届董事会届满之日止。 独立董事：潘立生、杨辉 2023 年 9 月 8 日 独立董事关于公司聘任财务总监的独立意见 根据《上市公司独立董事规则》、《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》、《深圳证券交易所股票上市规则》、《公司章程》 等有关规定，作为合肥美亚光电技术股份有限公司（以下简称"公司"）的独立 董事，本着认真、负责的态度，基于独立判断立场，现就公司聘任财务总监事项 发表独立意见如下： ...

证券代码：002690 证券简称：美亚光电 公告编号：2023-026 三、备查文件 合肥美亚光电技术股份有限公司 第五届董事会第四次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、董事会会议召开情况 合肥美亚光电技术股份有限公司（以下简称"公司"）于 2023 年 9 月 7 日 以电话或电子邮件的方式发出召开第五届董事会第四次会议的通知，会议于 2023 年 9 月 8 日上午 9:30 在公司会议室现场召开。本次会议应出席董事 5 人， 实际出席董事 5 人，会议由公司董事长田明先生主持。本次会议的召集、召开程 序均符合《公司法》和《公司章程》的有关规定。 二、 董事会会议审议情况 1、审议通过《关于聘任财务总监的议案》 表决结果：5 票同意，0 票反对，0 票弃权。 为确保公司财务管理工作的顺利开展，经总经理沈海斌女士提名，董事会同 意聘任陈凯先生为公司财务总监，任期自董事会审议通过之日起至第五届董事会 届满之日止。 详细内容请见刊登在 2023 年 9 月 9 日《证券时报》及巨潮资讯网 （http://www.cninfo.com.c ...

证券代码:002690 证券简称:美亚光电 合肥美亚光电技术股份有限公司 投资者关系活动记录表 | --- | --- | --- | |--------------|-----------------------------|--------------------------------| | | | 编号:T2023-006 | | | ■特定对象调研 | □分析师会议 | | 投资者关 | □媒体采访 | □业绩说明会 | | 系活动类别 | □新闻发布会 | □路演活动 | | | □现场参观 | □其他 (请文字说明其他活动内容) | | | 创金合信 皮劲松 宁银理财 | 丁雨婷 财通基金 王靖瑄 | | 活动参与人员 | 财达资管 常知常 中泰证券 | 姜楠宇 睿博私募 杨红杰 | | | 国寿养老 刘统 周晓文 刘崇武 | 兴业证券 郭亚男 丁志刚 | 接待人员 董事会秘书 程晓宏 时间 2023 年 8 月 31 日 地点 合肥美亚光电技术股份有限公司 形式 现场调研 1、公司 2023 年以来整体发展趋势? 答:国内经济发展大环境逐步稳定,但经济复苏仍然有较大压力。公 司经营上半年也经历 ...

Group 1: Financial Performance - In the first half of 2023, the company achieved a revenue of 967 million CNY, representing a year-on-year growth of approximately 7% [2] - The net profit for the same period was 346 million CNY, with a year-on-year increase of about 6.8% [2] - The revenue growth rate in Q2 2023 rebounded to 11.5% after a low point in Q1 [2] Group 2: Market and Product Performance - The company's dental-related business showed a recovery trend, with sales of dental CT products gradually increasing despite market competition [2] - The color selection machine business experienced a slowdown in growth due to a high base from the previous year, but the overseas market still holds significant potential [3] - The gross margin for color selection machines improved due to a stable competitive landscape and effective cost control [3] Group 3: Operational Insights - Contract liabilities increased by nearly 60% compared to the beginning of the year, indicating a significant rise in advance payments received [3] - Inventory levels rose due to a substantial increase in self-manufactured semi-finished products, exceeding 50%, in preparation for the upcoming sales peak [3] - The company is actively participating in major dental exhibitions and considering marketing activities based on actual conditions [4] Group 4: Future Outlook - The company aims to enhance the market competitiveness of its main products and expand sales through effective marketing strategies [4] - The "Meiya Meiya" dental health digital cloud platform has over a thousand clients using it, aimed at improving operational efficiency and patient experience [3] - The company plans to accelerate the market promotion of its spinal surgery navigation equipment and is progressing with the mobile CT project [4]

Financial Performance - The total revenue for the first half of 2023 was reported at 678,268,000.00 CNY, reflecting a decrease of 32,561,358.00 CNY compared to the previous period[6]. - The company allocated 542,614,400.00 CNY to shareholders during the reporting period, indicating a significant distribution of profits[6]. - The retained earnings at the end of the period were 881,748,400.00 CNY, demonstrating the company's ability to maintain earnings[3]. - The financial report for the first half of 2023 has not been audited, which may affect the perception of its reliability[20]. - The company will not distribute cash dividends, issue bonus shares, or convert reserves into capital stock[195]. Assets and Liabilities - The total assets at the end of the reporting period amounted to 2,368,162,135.41 CNY, showing a stable financial position[5]. - Total current assets decreased to $2.10 billion from $2.43 billion, reflecting a decline of 13.7% year-over-year[21]. - Total assets decreased to $2.96 billion from $3.31 billion, a reduction of 10.6% compared to the previous period[21]. - Short-term borrowings and other liabilities were not specified, indicating a focus on managing current liabilities effectively[21]. - The company reported a significant increase in accounts payable, which rose to $256.54 million from $242.73 million, an increase of 5.7%[21]. - Contract liabilities increased to $88.85 million from $64.14 million, showing a growth of 38.5% year-over-year[21]. Subsidiaries and Structure - The company has four subsidiaries included in the consolidated financial statements, indicating ongoing operational expansion[8]. - The company did not report any new subsidiaries added to the consolidation scope during the reporting period, maintaining its current structure[9]. - The company includes all subsidiaries under its control in the consolidated financial statements, reflecting the entire group's financial position and performance[63]. - The company has subsidiaries including Meiya Hong Kong and Meiya Medical[199]. Financial Management and Risk - The company is focusing on cash equivalents that meet specific liquidity criteria, ensuring strong cash management practices[22]. - The company is committed to maintaining a robust financial position by managing its financial assets and liabilities effectively[39]. - The company is actively monitoring credit risk and adjusting provisions for expected credit losses based on market conditions[39]. - The company assesses expected credit losses for financial instruments based on past events, current conditions, and reasonable forecasts of future economic conditions[41]. - The company recognizes goodwill when the acquisition cost exceeds the fair value of identifiable net assets acquired in a business combination[60]. Revenue Recognition - The company's revenue primarily comes from equipment sales, recognized when the customer gains control of the related goods or services[156]. - Revenue recognition for domestic sales occurs upon product delivery and customer acceptance, while for export sales, it is recognized after customs clearance and obtaining shipping documents[156]. Government Grants and Subsidies - Government grants are classified into asset-related and income-related, with asset-related grants reducing the carrying amount of related assets or recognized as deferred income[142][160]. - The company confirms government grants when there is evidence of meeting relevant conditions and expects to receive the funds[143]. - The accounting treatment for government grants includes recognizing income or reducing related costs based on the nature of the grant[144]. - The company emphasizes the importance of maintaining consistent accounting methods for similar government subsidy transactions[172]. Impairment and Asset Management - The company conducts annual impairment tests for goodwill and intangible assets with indefinite useful lives, regardless of whether there are indications of impairment[129]. - The company will assess the recoverable amount of long-term assets based on the higher of fair value less costs to sell and the present value of expected future cash flows[106]. - If the recoverable amount of long-term assets is lower than their carrying amount, the company will recognize an impairment loss in the current period[106]. Governance and Compliance - The company is Hefei Meiya Optoelectronics Technology Co., Ltd[199]. - The company is under the supervision of the China Securities Regulatory Commission[199]. - The main accounting firm for the company is Dahua Accounting Firm[199]. - The company is listed on the Shenzhen Stock Exchange[199]. - The company has a structured governance system including a board of directors and a supervisory board[199]. - The company operates under the Company Law of the People's Republic of China[199]. Reporting and Future Outlook - The reporting period covers from January 1, 2023, to June 30, 2023[199]. - The management has detailed the risks faced by the company and the corresponding countermeasures in the "Management Discussion and Analysis" section[182]. - The report includes forward-looking statements regarding future plans, which do not constitute a substantive commitment to investors[194]. - The financial performance metrics will be detailed in the upcoming sections[200].

Financial Performance - The company's operating revenue for Q1 2023 was CNY 406,964,645.20, representing a 1.26% increase compared to CNY 401,892,660.83 in the same period last year[19]. - The net profit attributable to shareholders for Q1 2023 was CNY 125,032,072.76, reflecting a 10.05% increase from CNY 113,615,316.77 year-on-year[19]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 123,163,392.59, up 16.13% from CNY 106,060,530.46 in the previous year[19]. - Basic earnings per share for Q1 2023 were CNY 0.1423, a 10.05% increase from CNY 0.1293 in the previous year[19]. - Total revenue for the period was ¥406,964,645.20, slightly up from ¥401,892,660.83, indicating a growth of about 1.67%[40]. - Total operating costs decreased to ¥267,578,566.10 from ¥284,682,327.54, representing a reduction of approximately 6.02%[40]. - Total comprehensive income attributable to the parent company reached ¥130,433,697.15, up from ¥69,208,940.24 in the previous period[35]. Cash Flow - The net cash flow from operating activities improved significantly to CNY 845,565.26, compared to a negative CNY 147,343,968.04 in the same period last year, marking a 100.57% increase[19]. - Net cash flow from operating activities increased by 100.57% compared to the same period last year, mainly due to an increase in cash received from sales and a decrease in procurement payments[22]. - Cash and cash equivalents increased by 1,015.90% compared to the same period last year, mainly due to an increase in cash received from sales and a decrease in procurement payments[25]. - Operating cash inflow totaled ¥423,890,182.85, compared to ¥363,423,311.45 in the previous period, reflecting a growth of approximately 16.67%[36]. - The net increase in cash and cash equivalents was $111,605,216.10, compared to a decrease of $12,185,346.62 in the previous period[43]. - The ending balance of cash and cash equivalents was $1,522,704,200.70, up from $1,036,867,627.17 in the previous period[43]. Assets and Liabilities - Total assets at the end of Q1 2023 were CNY 3,350,645,162.64, a 1.08% increase from CNY 3,314,919,654.11 at the end of the previous year[19]. - The equity attributable to shareholders increased to CNY 2,787,833,990.48, up 5.23% from CNY 2,649,221,170.17 at the end of the previous year[19]. - Current liabilities decreased to ¥497,809,507.27 from ¥600,447,530.91, showing a reduction of about 17.09%[39]. - Non-current assets totaled ¥832,549,115.25, a slight increase from ¥827,225,875.22[39]. Shareholder Information - The company reported a total of 18,805 common shareholders at the end of the reporting period[12]. - The largest shareholder, Tian Ming, holds 60.90% of the shares, amounting to 537,462,900 shares[12]. Government Subsidies and Other Financials - The company recognized government subsidies amounting to CNY 1,332,818.23 during the reporting period[2]. - Financial expenses increased by 91.77% compared to the same period last year, mainly due to an increase in exchange losses[22]. - Interest income increased by 609.67% compared to the same period last year, mainly due to an increase in interest income from US dollar deposits[22]. - Accounts receivable financing decreased by 39.45% compared to the beginning of the period, primarily due to a reduction in bank acceptance bills not endorsed at the end of the period[22]. - Prepayments decreased by 69.38% compared to the beginning of the period, mainly due to a reduction in advance payments for materials[22]. - Other receivables increased by 127.62% compared to the beginning of the period, mainly due to an increase in unreimbursed deposits and service fees at the end of the period[22]. Audit Information - The company’s first quarter report was not audited[44].

Financial Performance - The total cash inflow from operating activities for 2022 was ¥2,219,335,436.48, representing a year-on-year increase of 5.62% compared to ¥2,101,155,035.15 in 2021[8]. - The company's revenue for the year 2022 was approximately ¥18.98 million, with a net profit of ¥827,168.61[49]. - The company aims for a revenue growth of no less than 17% in 2023 compared to 2022[51]. - The company reported a total of ¥10,950,199.72 in investment income, accounting for 1.31% of total profit, primarily from bank financial product investments[9]. - The total distributable profit for the company was 769,123,482.00 CNY[102]. Cash Flow and Investments - The net cash flow from investing activities increased by 58.67% year-on-year, primarily due to a reduction in cash management principal payments[9]. - The company reported a total of 911,070,930.61 RMB invested in fundraising projects by December 31, 2022[43]. - As of December 31, 2022, the remaining balance of raised funds was 19,276,416.98 RMB[43]. - The company utilized 96,000,000.00 RMB of the raised funds during the 2022 fiscal year[43]. - The company has cumulatively distributed over ¥3 billion in cash dividends since its listing[70]. Operational Efficiency and Management - The company has established a complete management system for independent operations, including financial management and quality control[31]. - The company is focusing on enhancing management efficiency through digital and intelligent upgrades[52]. - The company has implemented a multi-level management system centered on customer service to optimize management rules and assessment mechanisms[52]. - The company plans to further streamline and improve its management system and operational mechanisms in response to external and internal changes[55]. - The company has maintained effective internal financial reporting controls, with no major deficiencies identified[135]. Employee Development and Compensation - The company will continue to emphasize talent development and optimize its internal and external training systems to enhance employee capabilities[22]. - The company emphasizes the importance of competitive compensation and career development to retain core talent amidst industry competition[24]. - The total number of employees at the end of the reporting period was 1,307, with 539 being technical staff and 216 in sales[97]. - The company has implemented a comprehensive salary system based on job value and performance, ensuring competitive compensation for employees[99]. - A total of 75,400 shares of restricted stock were granted to 321 incentive targets as part of the stock incentive plan[103]. Environmental and Social Responsibility - The company is committed to reducing carbon emissions and has integrated low-carbon practices into daily management[65]. - The company has not experienced any major environmental pollution incidents during the reporting period[66]. - The company strictly adheres to labor laws and has established comprehensive employment management systems to ensure employee welfare and rights[71]. - The company emphasizes the protection of shareholder and creditor rights through transparent governance and information disclosure[68]. Shareholder Engagement and Governance - The company has implemented effective communication channels to ensure fair information access for all shareholders[29]. - The company has held two shareholder meetings during the reporting period, adhering to legal and procedural requirements[28]. - The company’s board meetings were held regularly, with significant decisions made regarding quarterly reports and stock incentive plans[91]. - The company has a performance assessment target for the restricted stock incentive plan for the years 2022-2023[107]. - The company emphasizes a profit distribution mechanism that balances investor returns and sustainable development[121]. Product Development and Market Strategy - The company is focused on technology innovation and product iteration to increase market share and achieve stable revenue growth[25]. - The company has formed a product lineup for oral CBCT, which is widely used in various clinical applications, enhancing its market competitiveness[137]. - The company is actively pursuing industrial internet projects in the food processing and oral medical sectors, aiming to build an industrial internet ecosystem[139]. - The company has developed multiple series of products in the field of optoelectronic identification technology, with some technologies reaching industry-leading levels[163]. Financial Audits and Compliance - The internal control evaluation report indicates that 100% of the total assets and operating income of the evaluated units are included in the consolidated financial statements[82]. - There were no significant defects found in the internal control audit report, and the company received a standard unqualified opinion[86]. - The company has not identified any significant deficiencies in non-financial reporting internal controls as of the evaluation report benchmark date[162]. - The company has implemented internal control system improvements and strengthened internal audit supervision to enhance operational compliance and risk management[161].